Nadia Noorzai, Ccrp
About Nadia Noorzai, Ccrp
Nadia Noorzai, CCRP, is the Global Clinical Operations Leader for Oncology at BeiGene, with extensive experience in managing clinical trials and expertise in adaptive design and master protocols.
Global Clinical Operations Leader - Oncology at BeiGene
Nadia Noorzai currently serves as the Global Clinical Operations Leader for Oncology at BeiGene. Based in Thousand Oaks, California, she operates in a hybrid work environment. Her role encompasses overseeing clinical trials and operations in the oncology therapeutic area, ensuring the execution and quality of clinical programs. Nadia's responsibilities likely include strategic planning and excelling in the adaptive design and master protocols for oncology and inflammation.
Previous Experience at Amgen
Nadia Noorzai held multiple positions at Amgen, including Executive Director, Clinical Program Operations, and Head, Program Resource Management. She was involved in clinical program operations and resource management, contributing to strategic planning and execution of early development programs in general medicine and oncology. Her tenure at Amgen involved remote work, emphasizing her adaptability and efficiency in managing clinical trials and operations from a distance.
Clinical Operations Roles at Spectrum Pharmaceuticals and NanoString Technologies
Before joining BeiGene, Nadia served as Executive Director of Clinical Operations at Spectrum Pharmaceuticals, Inc. in Orange County, California, where she managed clinical operations for 1 year. Additionally, she was the Senior Director of Clinical Operations and Alliance Management at NanoString Technologies, Inc. in the Greater Seattle Area. In both roles, she was responsible for overseeing clinical trial operations and alliance management, reflecting her capacity for leadership in managing cross-functional teams.
Educational Background in Healthcare Management
Nadia Noorzai holds a Master of Public Health (MPH) in Healthcare Management from Southern New Hampshire University, which she attained between 2021 and 2023. She also studied at the University of Denver for two years and achieved a Bachelor of Science degree in Biology and Chemistry from the University of Colorado Boulder. Her academic background underpins her expertise in clinical operations and healthcare management, equipping her with the necessary skills to lead complex clinical trials and research projects.
Expertise in Clinical Trials and Companion Diagnostic Development
With extensive experience in managing clinical trials across therapeutic areas such as cardiovascular, ophthalmology, and vaccines, Nadia specializes in adaptive design and master protocols, particularly for oncology and inflammation. Her expertise includes significant work in companion diagnostic (CDx) development, showcasing her proficiency in aligning diagnostics with therapeutic products. This specialized knowledge positions her as a key player in the field of clinical operations, particularly in oncology.